Compare Cytokinetics Inc (CYTK) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Cytokinetics Inc trades at $76.75 (market cap $10.63B), while Virgin Galactic Holdings, Inc. trades at $3.31 (market cap $498.02M). The key difference: Cytokinetics Inc is far larger — about 21.3× Virgin Galactic Holdings, Inc.'s market cap, and Cytokinetics Inc is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.
| CYTK | SPCE | |
|---|---|---|
Market Cap | $10.63B | $498.02M |
Sector | Technology | Industrials |
52-Week High | $87.26 | $7.52 |
52-Week Low | $34.31 | $2.17 |
Enterprise Value | $10.74B | $597.87M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
